8-K: Nanophase Technologies Reports Flat Revenue, Increased Losses for 2023, Secures $6 Million Financing

Nanophase Technologies reported flat full-year revenue of $37.3 million for 2023, alongside increased net losses, but secured a $6 million financing package and won a major industry award.

Summary

• Nanophase Technologies Corporation announced its financial results for the fourth quarter and full year ended December 31, 2023.
• Full-year revenue remained flat at $37.3 million compared to 2022.
• Solsence revenue increased by 9% to $25.2 million, while Personal Care Ingredients and Advanced Materials revenues decreased by 17% and 9%, respectively.
• The company experienced a net loss of $4.4 million for the full year, or $0.09 per share, compared to a $2.6 million loss in 2022, or $0.05 per share.
• The fourth quarter net loss was $2.1 million, compared to $2.0 million in the same period of 2022.
• The increased loss was primarily due to supply chain issues and inefficiencies in Q4, as well as $1.3 million in legal fees.
• A $6 million financing package was secured in March 2024.
• The company expects $35 million in shipped and open purchase orders for 2024, with more orders anticipated in the second and third quarters.
• Operational improvements and supply chain enhancements are underway, including the addition of an experienced buyer and upgrades to manufacturing facilities.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the company secured financing and won awards, the flat revenue and increased losses are concerning. The forward-looking statements are cautiously optimistic, but the company needs to demonstrate improved financial performance.

Positives

• Solsence revenue increased by 9% year-over-year, indicating strong performance in that segment.
• The company secured a $6 million financing package, providing much-needed capital.
• Nanophase won a major industry award for their Soft Glow 50+ product, demonstrating product innovation.
• The company was recognized as one of the world's most innovative companies by Fast Company.
• Operational improvements and supply chain enhancements are underway, which are expected to improve future results.
• The company has $35 million in shipped and open purchase orders for 2024, indicating strong demand.

Negatives

• Full-year revenue remained flat compared to the previous year.
• Personal Care Ingredients and Advanced Materials revenues decreased by 17% and 9%, respectively.
• The company experienced a net loss of $4.4 million for the full year, an increase from the $2.6 million loss in 2022.
• The fourth quarter net loss was $2.1 million, compared to $2.0 million in the same period of 2022.
• Supply chain issues and inefficiencies in Q4 significantly impacted profitability.
• The company incurred $1.3 million in legal fees related to litigation.

Risks

• The company is dependent on a limited number of key customers, which could impact revenue if a customer cancels an order.
• There is uncertain demand for the company's products, which could affect future sales.
• The company's manufacturing capacity and product mix flexibility could be challenged by customer demand.
• The company has limited marketing experience, which could hinder growth.
• The company is dependent on patents and protection of proprietary information, which could be at risk.
• The company is involved in litigation, which could result in further financial losses.
• New government regulations could be difficult or costly to comply with.
• The company's electronic trading venue may not be maintained.

Future Outlook

The company expects $35 million in shipped and open purchase orders for 2024, with more orders anticipated in the second and third quarters. They also anticipate improved operational efficiency and lower litigation costs in 2024.

Management Comments

• Jess Jankowski, President and CEO, stated that while the third and fourth quarters experienced supply chain issues, they are confident in their plan to manage critical areas and add efficiency to operations.
• Jankowski also mentioned that the company has the right financing in place to set them up for a strong 2024.
• Kevin Cureton, Chief Operating Officer, commented on the work to transform management practices to improve execution and accountability.
• Cureton also highlighted the addition of an experienced Buyer to improve supply chain processes.

Industry Context

The company operates in the beauty and life science sectors, which are experiencing growth in demand for mineral-based and scientifically-driven solutions. The company's focus on innovation and sustainability aligns with current industry trends. The award wins highlight the company's position as a leader in the beauty industry.

Comparison to Industry Standards

• Nanophase's flat revenue growth contrasts with some competitors in the beauty and personal care space who have seen more significant growth, such as large multinational cosmetic companies.
• The company's net loss of $4.4 million is a concern, as many established players in the industry are profitable, such as Estee Lauder and L'Oreal.
• The 9% growth in Solsence revenue is a positive sign, but the declines in other segments indicate a need for diversification or improved performance in those areas.
• The $6 million financing package is a positive step, but the company will need to demonstrate improved financial performance to attract further investment.
• The company's award wins are a positive sign of product innovation, but they need to translate into improved financial results.

Legal Proceedings

• The company incurred $1.3 million in legal fees related to litigation in 2023.

Related Party Transactions

• The company has a line of credit and debt with related parties.

Stakeholder Impact

• Shareholders may be concerned about the increased net loss and flat revenue.
• Employees may be impacted by the ongoing operational changes and restructuring.
• Customers may benefit from the company's product innovations and improved supply chain.
• Suppliers may be affected by the company's supply chain enhancements.
• Creditors may be impacted by the company's financial performance and debt levels.

Next Steps

• The company will host a conference call on March 21st, 2024, to discuss financial results.
• The company plans to continue operational improvements and supply chain enhancements.
• The company will complete the validation of in-house micro-testing labs in summer 2024.
• The company will complete the manufacturing consolidation process in late summer 2024.

Key Dates

Keywords

Nanophase Technologies, Solsence, financial results, revenue, net loss, financing, supply chain, beauty industry, cosmetics, skincare, advanced materials